Italian CDMO Olon has announced the start of a construction on a €22 million facility for the production of ultra-potent compounds. These are aimed for use mainly as payloads and payload-linkers for antibody-drug conjugates (ADCs) at its site at Rodano, near Milan.
BASF has started up a new supercomputer at its Ludwigshafen verbund site in Germany. Like its predecessor, the new machine will be called Quriosity but will have three petaflops of computing power compared to 1.75.
Japan’s Nippon Shokubai has officially opened a 100,000 tonnes/year acrylic acid (AA) plant that was built at a cost of about $200 million at Cilegon, Banten, Indonesia. This takes its global capacity to 980,000 tonnes, of which 540,000 are in Japan itself.
Oxo chemicals firm OQ Chemicals has announced a two-year cost-saving programme that includes realignment and workforce reductions in Germany. This was attributed to high raw material and energy prices, plus inflation rates, particularly in Europe.
Global Healthcare Opportunities (GHO), a European specialist investor in healthcare, and Partners Group, a global private markets firm, have both invested in Sterling Pharma Solutions, a CDMO owned by GHO. The exact amounts have not been disclosed.
Solvay has officially opened its application development lab in Shanghai.
Current Issue
Chemours, DuPont and Corteva have reached an agreement in principle to resolve all per- and polyfluoroalkyl
Singapore-based Sustainable Chemistry for the Textile Industry (SCTI), an alliance of six major producers o
BASF has announced plans to boost its global capacity for alkyl polyglucosides (APGs) by expanding its site
According to a lifecycle assessment carried out by an independent consultant and verified by a panel of thr
Most Popular
BASF has started up a new supercomputer at its Ludwigshafen verbund site in Germany. Like its predecessor, the new machine will be called Quriosity but will have three petaflops of computing power compared to 1.75. It will also be the largest supercomputer used in industrial chemical research.
Global Healthcare Opportunities (GHO), a European specialist investor in healthcare, and Partners Group, a global private markets firm, have both invested in Sterling Pharma Solutions, a CDMO owned by GHO. The exact amounts have not been disclosed.
Oxo chemicals firm OQ Chemicals has announced a two-year cost-saving programme that includes realignment and workforce reductions in Germany. This was attributed to high raw material and energy prices, plus inflation rates, particularly in Europe. Last year alone, rising energy costs amounted to “a high three-digit million Euro figure”.
